{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T06:40:26Z","timestamp":1774939226454,"version":"3.50.1"},"reference-count":45,"publisher":"Impact Journals, LLC","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,4,5]]},"DOI":"10.18632\/oncotarget.7636","type":"journal-article","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T03:07:29Z","timestamp":1456283249000},"page":"18135-18145","source":"Crossref","is-referenced-by-count":18,"title":["Stereotactic radiation therapy for oligometastases or oligorecurrence within mediastinal lymph nodes"],"prefix":"10.18632","volume":"7","author":[{"given":"Huan-Huan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, CyberKnife Center, and Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas G.","family":"Zaorsky","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao-Bin","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, CyberKnife Center, and Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-Liang","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, CyberKnife Center, and Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Thoracic Cancer and Huaxi Student Society of Oncology Research, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Chun","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, CyberKnife Center, and Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Qing","family":"Zhuang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, CyberKnife Center, and Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Tong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, CyberKnife Center, and Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-Jun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, CyberKnife Center, and Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Yong","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, CyberKnife Center, and Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, CyberKnife Center, and Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Shan","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,2,23]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1200\/JCO.2012.45.9651","article-title":"Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy","volume":"31","author":"Weichselbaum","year":"2013","journal-title":"J Clin Oncol"},{"key":"2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejcts.2005.03.016","article-title":"Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases","volume":"28","author":"Morandi","year":"2005","journal-title":"Eur J Cardiothorac Surg"},{"key":"3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nrclinonc.2011.75","article-title":"The role of local therapy in the management of lung and liver oligometastases","volume":"8","author":"Dawson","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"4","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrclinonc.2014.96","article-title":"The oligometastatic state-separating truth from wishful thinking","volume":"11","author":"Lo","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1200\/JCO.2006.09.7469","article-title":"Stereotactic body radiation therapy in multiple organ sites","volume":"25","author":"Xing","year":"2007","journal-title":"J Clin Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1200\/JCO.2008.21.7299","article-title":"Using a bigger hammer: the role of stereotactic body radiotherapy in the management of oligometastases","volume":"27","author":"Lawrence","year":"2009","journal-title":"J Clin Oncol"},{"key":"7","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S1470-2045(12)70510-7","article-title":"Stereotactic body radiotherapy for oligometastases","volume":"14","author":"Eeles","year":"2013","journal-title":"Lancet Oncol"},{"key":"8","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1200\/JCO.2014.55.9567","article-title":"Radical irradiation of extracranial oligometastases","volume":"32","author":"Milano","year":"2014","journal-title":"J Clin Oncol"},{"key":"9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/annonc\/mdt537","article-title":"Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival","volume":"25","author":"De Ridder","year":"2014","journal-title":"Ann Oncol"},{"key":"10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijrobp.2014.10.021","article-title":"Stereotactic body radiation therapy for oligometastases to the lung: a phase 2 study","volume":"91","author":"Verhoef","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11","doi-asserted-by":"publisher","first-page":"15690","DOI":"10.18632\/oncotarget.3704","article-title":"Clinical evaluation of stereotactic radiation therapy for recurrent or second primary mediastinal lymph node metastases originating from non-small cell lung cancer","volume":"6","author":"Zaorsky","year":"2015","journal-title":"Oncotarget"},{"key":"12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0167-8140(01)00478-9","article-title":"Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial","volume":"62","author":"Granone","year":"2002","journal-title":"Radiother Oncol"},{"key":"13","first-page":"265","article-title":"A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma","volume":"86","author":"Chammard","year":"1999","journal-title":"Groupe d'Etude et de Traitement des Cancers Bronchiques Cancer"},{"key":"14","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.ijrobp.2009.09.070","article-title":"Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation","volume":"78","author":"Rebueno","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.radonc.2011.09.012","article-title":"Toxicity after reirradiation of pulmonary tumors with stereotactic body radiotherapy","volume":"101","author":"Lindberg","year":"2011","journal-title":"Radiother Oncol"},{"key":"16","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1097\/JTO.0b013e31825f22ce","article-title":"Stereotactic ablative radiotherapy for reirradiation of locally recurrent lung tumors","volume":"7","author":"Le","year":"2012","journal-title":"J Thorac Oncol"},{"key":"17","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4236\/jct.2011.22024","article-title":"Salvage SBRT for previously irradiated lung cancer","volume":"2","author":"Solhjem","year":"2011","journal-title":"J Cancer Ther"},{"key":"18","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.radonc.2013.11.017","article-title":"Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment","volume":"110","author":"Blackstock","year":"2014","journal-title":"Radiother Oncol"},{"key":"19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.radonc.2009.04.001","article-title":"Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer","volume":"93","author":"Beltramo","year":"2009","journal-title":"Radiother Oncol"},{"key":"20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijrobp.2008.07.020","article-title":"Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases from uterine cervical and corpus cancer","volume":"74","author":"Yoo","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"21","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3346\/jkms.2009.24.3.488","article-title":"Stereotactic body radiotherapy for isolated para-aortic lymph node recurrence after curative resection in gastric cancer","volume":"24","author":"Cho","year":"2009","journal-title":"J Korean Med Sci"},{"key":"22","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.3748\/wjg.15.6091","article-title":"Stereotactic body radiotherapy for isolated paraaortic lymph node recurrence from colorectal cancer","volume":"15","author":"Yang","year":"2009","journal-title":"World J Gastroenterol"},{"key":"23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.otohns.2009.12.034","article-title":"Stereotactic body radiotherapy for refractory cervical lymph node recurrence of nonanaplastic thyroid cancer","volume":"142","author":"Yoo","year":"2010","journal-title":"Otolaryngol Head Neck Surg"},{"key":"24","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ijrobp.2010.05.032","article-title":"Clinical outcome of hypofractionated stereotactic radiotherapy for abdominal lymph node metastases","volume":"81","author":"Mancosu","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"25","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ijrobp.2010.11.031","article-title":"Robotic image-guided stereotactic radiotherapy for isolated recurrent primary, lymph node or metastatic prostate cancer","volume":"82","author":"Fariselli","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/jso.23058","article-title":"High dose stereotactic body radiotherapy using three fractions for colorectal oligometastases","volume":"106","author":"Cho","year":"2012","journal-title":"J Surg Oncol"},{"key":"27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/COC.0b013e3182610878","article-title":"Linac-based stereotactic body radiotherapy for oligometastatic patients with single abdominal lymph node recurrent cancer","volume":"37","author":"Ronchi","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.prro.2014.09.006","article-title":"Stereotactic body radiation therapy for abdominal and pelvic oligometastases: dosimetric targets for safe and effective local control","volume":"5","author":"Wang","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"29","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1016\/j.clgc.2014.12.014","article-title":"Salvage stereotactic body radiotherapy for patients with prostate cancer with isolated lymph node metastasis: A single-center experience","volume":"13","author":"Carosi","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00130404-200607000-00006","article-title":"Local recurrence following initial resection of NSCLC: salvage is possible with radiation therapy","volume":"12","author":"Marks","year":"2006","journal-title":"Cancer J"},{"key":"31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00130404-200607000-00006","article-title":"Local recurrence following initial resection of NSCLC: salvage is possible with radiation therapy","volume":"12","author":"Marks","year":"2006","journal-title":"Cancer J"},{"key":"32","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1200\/JCO.2005.55.405","article-title":"Combined chemoradiotherapy regimens of pacitaxel and carboplatin for locally advanced non-small cell lung cancer: a randomized phase II locally advanced multi-modality protocol","volume":"23","author":"Bonomi","year":"2005","journal-title":"J Clin Oncol"},{"key":"33","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1200\/JCO.2005.03.070","article-title":"Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Fran\u00e7ais de Pneumo-Canc\u00e9rologie NPC 95-01 study","volume":"23","author":"Thomas","year":"2005","journal-title":"J Clin Oncol"},{"key":"34","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1200\/JCO.2005.05.4163","article-title":"Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99\/97 by the Bronchial Carcinoma Therapy Group","volume":"24","author":"Schmidt","year":"2006","journal-title":"J Clin Oncol"},{"key":"35","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMc1203770","article-title":"Central-airway necrosis after stereotactic body-radiation therapy","volume":"366","author":"Rengan","year":"2012","journal-title":"N Engl J Med"},{"key":"36","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1378\/chest.111.6.1718","article-title":"Regional lymph node classification for lung cancer staging","volume":"111","author":"Dresler","year":"1997","journal-title":"Chest"},{"key":"37","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.ijrobp.2010.07.1977","article-title":"Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus","volume":"81","author":"Quint","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijrobp.2008.06.1939","article-title":"Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation","volume":"74","author":"Mueller","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"39","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s10147-004-0435-z","article-title":"Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the Japanses experience","volume":"9","author":"Nagata","year":"2004","journal-title":"Int J Clin Oncol"},{"key":"40","first-page":"395","article-title":"What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation","volume":"115","author":"Den","year":"2015","journal-title":"Radiother Oncol"},{"key":"41","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.radonc.2013.01.004","article-title":"Outcomes of stereotactic ablative radiotherapy for central lung tumors: a systematic review","volume":"106","author":"Senan","year":"2013","journal-title":"Radiother Oncol"},{"key":"42","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Galvin","year":"2010","journal-title":"JAMA"},{"key":"43","unstructured":"Radiation Therapy Oncology Group. RTOG 0813: Seamless phase I\/II study of stereotactic lung radiotherapy (SBRT) for early stage, centrally located, non-small cell lung cancer (NSCLC) in medically inoperable patients. Available at http:\/\/www.rtog.org\/ClinicalTrials\/ProtocolTable\/StudyDetails.aspx?study=0813."},{"key":"44","unstructured":"NRG Oncology. A phase 1 study of stereotactic body radiotherapy (SBRT) for the treatment of multiple metastases. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02206334?term=NRG-BR001&rank=1."},{"key":"45","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1)","volume":"45","author":"Bogaerts","year":"2009","journal-title":"Eur J Cancer"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7636","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T18:51:54Z","timestamp":1589223114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,23]]},"references-count":45,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2016,4,5]]}},"alternative-id":["7636","26919113"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.7636","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,23]]}}}